Re: A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis

We read with great interest the recent contribution of Dr. Mello et al. in their study, entitled “A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis” [ [1] Mello M.F. Locali R.F. Araujo R.M. Reis J.N. Saiovici S. Mello L.F. et al. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis. J Pediatr Urol. 2023; S1477–513100008-6 Google Scholar ]. They showed that the use of alarms is the most effective treatment of monosymptomatic enuresis (MNE) with superior results when compared to desmopressin and imipramine [ [1] Mello M.F. Locali R.F. Araujo R.M. Reis J.N. Saiovici S. Mello L.F. et al. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis. J Pediatr Urol. 2023; S1477–513100008-6 Google Scholar ]. But we would like to contribute some points regarding their paper. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresisJournal of Pediatric UrologyVol. 19Issue 3PreviewMonosymptomatic enuresis (MNE) results from a pathogenic triad that may include lack of vasopressin secretion during sleep, reduced functional bladder capacity and inability to wake up during sleep. The treatment of MNE can be performed through behavioral therapy, use of alarms or medications such as desmopressin and imipramine. Full-Text PDF Response to letter to the editor re a prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresisJournal of Pediatric UrologyVol. 19Issue 4PreviewFirst, I would like to thank the authors of this commentary on our manuscript for their interest and contributions. We apologize for the typos, but here are the point-by-point corrections. Regarding the age range of the of study participants which was noted to be inconsistent, the inclusion criteria were: Age between 6 and 16 years old. Full-Text PDF